Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based company, which is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing drugs and delivery methods. The Company seeks to develop ketamine and derivatives and other psychedelic products from its Internet protocol (IP) development platform. The Company has clinic operations in the Canadian cities of Mississauga, Toronto, Kitchener-Waterloo, Ottawa and Montreal. The Company, through its wholly owned subsidiary, the Canadian Rapid Treatment Center of Excellence Inc., it operates multidisciplinary community-based clinics offering rapid-acting treatments for depression located in Mississauga, Toronto, Ottawa, Kitchener and Montreal. Its subsidiaries include Altmed Capital Corp., Artisan Growers Ltd., KetaMD, Inc., Novo Formulations Ltd. and Tassili Life Sciences Corp.


CSE:BRAX - Post by User

Post by InFactsWeTruston Jun 28, 2020 3:20pm
496 Views
Post# 31200761

Just a theory

Just a theorySo how about this theory:

SHRM purposely didnt file paperwork so they don't have to disclose info to competitors.  Announcing their intentions to buy a bunch of Ketamine clinics  a while back may not have been the smartest move as their competitors are going to make that pricier now.

Management team is fabulous at making money but not so experienced at running a publicly traded company.  This sector is HUGE.  Pot and SSRIs do nothing for mood for most people unless you like being high and/or disfunctional.  Psychedelics have the potential to WIPE OUT the Pharma antidepressant industry.

This is early days.  My bet is that these guys don't want to miss out on a huge opportunity by selling out too early.  Best case is they get a big Pharma to back them financially by taking a significant minority stake as a defensive move.  JNJ knows the potential of Ketamine for the masses.  I'm sure the others are nervously watching.

My biggest fear right now:  That insiders were related party in acquisitions in question.  Aside from that kind of news, I think you ride this for the long term.  Tempted to buy at these levels but I just want to make sure I can trust management so I think I'll wait for the news on the missing paperwork.   It would be very, very bad if the esteemed Roger McIntyre was found to be morally corrupt.
<< Previous
Bullboard Posts
Next >>